“As equity market performance and valuations return to more appropriate levels, the incentive and the ability to issue equity or IPO in a business becomes a viable option.” The Johannesburg ...
BioAge Labs, Inc. ( (BIOA) ) has released its Q3 earnings. Here is a breakdown of the information BioAge Labs, Inc. presented ...
Initiated Phase 2 STRIDES trial of azelaprag in combination with tirzepatide for obesityCompleted $238.3 million initial public offering and ...
The dramatically upsized IPO ties into an increasingly buoyant biotech financing environment, with a string of upsized ...
Meanwhile, BioAge Labs, which went public in late September, is up nearly 40 percent from its IPO price. It sold 11 million shares at $18 apiece, the second time it raised its terms. At least ...
Drug developers have achieved resounding success in the fall U.S. IPO market, with all the $100-million plus offerings since September upsized. Robust debuts by drug developers Bicara Therapeutics , ...
Septerna now offering 16 mln shares vs 15.3 mln shares earlier Sets IPO price at $18 a share Drug developer backed by Goldman, Third Rock Ventures Listing follows a spate of biotech IPOs since ...
Waaree Energies IPO, which saw a bumper response from investors during the bidding process, has now left investors wondering what are the odds of getting the allotment of shares after a stellar ...
How to Check Deepak Builders & Engineers IPO Allotment Status: Investors who have applied for the Deepak Builders & Engineers IPO can track the allotment status through the Bombay Stock Exchange ...
Deepak Builders IPO allotment is likely to take place today after the initial share sale of the company received 41.54 times subscription on the last day of the initial share sale. The Rs 260 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback